RxDoctor Payments Data

Katherine Mankus, PA

Physician Assistant · Boise, IDNPI 1366050353

Payments from drug & device makers

$1,586in general payments, 2019–2025

Across 53 payments — averaging $29.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$750
  • Medtronic$226
  • Pfizer$145
  • Sanofi-aventis U.S. LLC$143
  • Amgen$126
  • Johnson & Johnson$102
  • plus $95 from 4 others

What the payments were for

  • Food & beverage$1,52896%
  • Education$594%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,586 in reported general payments places this provider in the 75th percentile of 1,027 physician assistant providers in Idaho.

See all physician assistant providers in Idaho

Medicare billing

Part B allowed, 2024
$18,348
Medicare patients
236
Services billed
254

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban388$526,530
XareltoRivaroxaban87$93,391
MultaqDronedarone Hcl25$25,361
Flecainide Acetate146$4,824
SotalolSotalol Hcl179$4,510
Amiodarone Hcl130$4,317
Diltiazem 24hr Er (Cd)Diltiazem Hcl87$3,471
Metoprolol Succinate253$3,252
Mexiletine Hcl17$1,744
Digoxin61$1,545
Metoprolol Tartrate125$643
Cartia XtDiltiazem Hcl19$333
Diltiazem 24hr ErDiltiazem Hcl12$319
Diltiazem Hcl15$315
Warfarin Sodium31$300

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$145$526,530388 claims
Johnson & JohnsonXarelto$102$93,39187 claims
Sanofi-aventis U.S. LLCMultaq$143$25,36125 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,027 physician assistant providers in Idaho.

Other physician assistant in Boise

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →